Published in Bioorg Med Chem Lett on August 10, 2012
"Stormy waters ahead": global emergence of carbapenemases. Front Microbiol (2013) 2.74
The intrinsic resistome of bacterial pathogens. Front Microbiol (2013) 1.05
Assay platform for clinically relevant metallo-β-lactamases. J Med Chem (2013) 0.99
Overcoming resistance to β-lactam antibiotics. J Org Chem (2013) 0.90
Fragment-based inhibitor discovery against β-lactamase. Future Med Chem (2014) 0.76
Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev (2005) 12.07
Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 7.10
Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity. Chem Rev (2005) 4.48
Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem Pharmacol (2007) 2.87
Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Biochemistry (2000) 2.54
Metallo-beta-lactamases: novel weaponry for antibiotic resistance in bacteria. Acc Chem Res (2006) 2.46
Metallo-beta-lactamase: structure and mechanism. Curr Opin Chem Biol (1999) 2.06
The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria. Clin Microbiol Infect (2005) 1.60
The design of inhibitors for medicinally relevant metalloproteins. ChemMedChem (2007) 1.44
Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase. Chem Biol (1998) 1.41
Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-beta-lactamase. J Biol Chem (2001) 1.38
The 1.5-A structure of Chryseobacterium meningosepticum zinc beta-lactamase in complex with the inhibitor, D-captopril. J Biol Chem (2003) 1.35
Antibiotics: a shot in the arm. Nature (2004) 1.29
Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships. J Med Chem (2009) 1.27
Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrob Agents Chemother (2003) 1.22
Metallo-beta-lactamase inhibitors: promise for the future? Curr Opin Investig Drugs (2004) 1.18
A new role for old ligands: discerning chelators for zinc metalloproteinases. J Am Chem Soc (2006) 1.13
Design, synthesis, and SAR studies of 4-substituted methoxylbenzoyl-aryl-thiazoles analogues as potent and orally bioavailable anticancer agents. J Med Chem (2011) 1.09
Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies. J Med Chem (2011) 1.06
Structures of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes. ACS Med Chem Lett (2011) 1.04
Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase. J Med Chem (2009) 1.03
Analysis of the functional contributions of Asn233 in metallo-β-lactamase IMP-1. Antimicrob Agents Chemother (2011) 1.01
A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science (2008) 2.96
Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. Proc Natl Acad Sci U S A (2007) 2.00
Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl diphosphate synthase inhibitors: an X-ray and NMR investigation. J Am Chem Soc (2009) 1.75
Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies. J Am Chem Soc (2011) 1.66
The binary protein interactome of Treponema pallidum--the syphilis spirochete. PLoS One (2008) 1.59
Solid-state NMR, crystallographic, and computational investigation of bisphosphonates and farnesyl diphosphate synthase-bisphosphonate complexes. J Am Chem Soc (2006) 1.48
The protein network of bacterial motility. Mol Syst Biol (2007) 1.45
Systematic cloning of Treponema pallidum open reading frames for protein expression and antigen discovery. Genome Res (2003) 1.44
Apicoplast isoprenoid precursor synthesis and the molecular basis of fosmidomycin resistance in Toxoplasma gondii. J Exp Med (2011) 1.43
Probing regulon of ArcA in Shewanella oneidensis MR-1 by integrated genomic analyses. BMC Genomics (2008) 1.38
Transcriptome of Treponema pallidum: gene expression profile during experimental rabbit infection. J Bacteriol (2005) 1.30
Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays. BMC Microbiol (2008) 1.29
A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin. Infect Immun (2008) 1.28
Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L. J Med Chem (2012) 1.26
Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrob Agents Chemother (2003) 1.22
Photoaffinity antigens for human gammadelta T cells. J Immunol (2008) 1.19
Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation. J Med Chem (2008) 1.18
Analysis of the context dependent sequence requirements of active site residues in the metallo-beta-lactamase IMP-1. J Mol Biol (2004) 1.18
Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates. J Med Chem (2004) 1.16
Penicillin-derived inhibitors that simultaneously target both metallo- and serine-beta-lactamases. Bioorg Med Chem Lett (2004) 1.16
Co-crystal structures of PKG Iβ (92-227) with cGMP and cAMP reveal the molecular details of cyclic-nucleotide binding. PLoS One (2011) 1.14
Genome scale identification of Treponema pallidum antigens. Infect Immun (2005) 1.14
Multiple global suppressors of protein stability defects facilitate the evolution of extended-spectrum TEM β-lactamases. J Mol Biol (2010) 1.14
Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response. J Bacteriol (2002) 1.14
Physiological roles of ArcA, Crp, and EtrA and their interactive control on aerobic and anaerobic respiration in Shewanella oneidensis. PLoS One (2010) 1.13
Biochemical control of CARM1 enzymatic activity by phosphorylation. J Biol Chem (2009) 1.13
Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption. J Med Chem (2005) 1.12
Reactivity of antibodies from syphilis patients to a protein array representing the Treponema pallidum proteome. J Clin Microbiol (2006) 1.11
Amino acid sequence requirements at residues 69 and 238 for the SME-1 beta-lactamase to confer resistance to beta-lactam antibiotics. Antimicrob Agents Chemother (2003) 1.10
Dissecting the protein-protein interface between beta-lactamase inhibitory protein and class A beta-lactamases. J Biol Chem (2004) 1.10
Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1. Antimicrob Agents Chemother (2005) 1.09
NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model. J Am Chem Soc (2008) 1.09
Evaluation of penicillin-based inhibitors of the class A and B beta-lactamases from Bacillus anthracis. Biochem Biophys Res Commun (2004) 1.08
A fitness cost associated with the antibiotic resistance enzyme SME-1 beta-lactamase. Genetics (2007) 1.06
Determinants of binding affinity and specificity for the interaction of TEM-1 and SME-1 beta-lactamase with beta-lactamase inhibitory protein. J Biol Chem (2003) 1.06
Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies. J Med Chem (2011) 1.06
Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase. ACS Med Chem Lett (2013) 1.05
Genetic and structural characterization of an L201P global suppressor substitution in TEM-1 beta-lactamase. J Mol Biol (2008) 1.05
Structures of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes. ACS Med Chem Lett (2011) 1.04
Coordination chemistry based approach to lipophilic inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase. J Med Chem (2009) 1.03
Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 beta-lactamase. Protein Sci (2009) 1.03
Functional analysis of active site residues of the fosfomycin resistance enzyme FosA from Pseudomonas aeruginosa. J Biol Chem (2005) 1.01
Analysis of the functional contributions of Asn233 in metallo-β-lactamase IMP-1. Antimicrob Agents Chemother (2011) 1.01
On the histone lysine methyltransferase activity of fungal metabolite chaetocin. J Med Chem (2013) 0.99
BAC library of T. pallidum DNA in E. coli. Genome Res (2002) 0.98
Structural basis of substrate specificity and protease inhibition in Norwalk virus. J Virol (2013) 0.98
Epitope mapping and use of epitope-specific antisera to characterize the VP5* binding site in rotavirus SA11 NSP4. Virology (2007) 0.98
Structural insight into the kinetics and DeltaCp of interactions between TEM-1 beta-lactamase and beta-lactamase inhibitory protein (BLIP). J Biol Chem (2008) 0.97
Conformational polymorphism in sulfonylurea drugs: electronic structure analysis. J Phys Chem B (2010) 0.97
Deep sequencing of systematic combinatorial libraries reveals β-lactamase sequence constraints at high resolution. J Mol Biol (2012) 0.96
A medicinal chemistry perspective for targeting histone H3 lysine-79 methyltransferase DOT1L. J Med Chem (2013) 0.95
Bisphosphonate inhibition of the exopolyphosphatase activity of the Trypanosoma brucei soluble vacuolar pyrophosphatase. J Med Chem (2005) 0.95
Synthesis, Activity and Metabolic Stability of Non-Ribose Containing Inhibitors of Histone Methyltransferase DOT1L. Medchemcomm (2013) 0.95
An amino-terminal signal peptide of Vfr protein negatively influences RopB-dependent SpeB expression and attenuates virulence in Streptococcus pyogenes. Mol Microbiol (2011) 0.95
Structural studies of Vgamma2Vdelta2 T cell phosphoantigens. Chem Biol (2006) 0.94
Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates. J Med Chem (2006) 0.93
Thermodynamic investigation of the role of contact residues of beta-lactamase-inhibitory protein for binding to TEM-1 beta-lactamase. J Biol Chem (2007) 0.92
An analysis of why highly similar enzymes evolve differently. Genetics (2003) 0.91
Regioselective radical aminofluorination of styrenes. Angew Chem Int Ed Engl (2014) 0.90
Structural and biochemical evidence that a TEM-1 beta-lactamase N170G active site mutant acts via substrate-assisted catalysis. J Biol Chem (2009) 0.90
Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens. Biochemistry (2015) 0.90
A broad-spectrum peptide inhibitor of beta-lactamase identified using phage display and peptide arrays. Protein Eng (2003) 0.90
Molecular basis for the catalytic specificity of the CTX-M extended-spectrum β-lactamases. Biochemistry (2014) 0.90
Activity of nitrogen-containing and non-nitrogen-containing bisphosphonates on tumor cell lines. J Med Chem (2006) 0.89
Crystal structure of Bacillus anthracis virulence regulator AtxA and effects of phosphorylated histidines on multimerization and activity. Mol Microbiol (2014) 0.89
A high-throughput percentage-of-binding strategy to measure binding energies in DNA-protein interactions: application to genome-scale site discovery. Nucleic Acids Res (2008) 0.89
Using peptide arrays to define nuclear carrier binding sites on nucleoporins. Methods (2006) 0.89
Generation and validation of a Shewanella oneidensis MR-1 clone set for protein expression and phage display. PLoS One (2008) 0.88
Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples. J Clin Microbiol (2013) 0.87
Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure-activity relationship, and selective antitumor activity. J Med Chem (2014) 0.87
Crystallographic Analysis of Rotavirus NSP2-RNA Complex Reveals Specific Recognition of 5' GG Sequence for RTPase Activity. J Virol (2012) 0.86
Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae. PLoS One (2013) 0.86
Thermodynamic Investigation of Inhibitor Binding to 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase. ACS Med Chem Lett (2012) 0.86
Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases. J Biol Chem (2013) 0.85
Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site. Antimicrob Agents Chemother (2012) 0.85
Antimalarial and Structural Studies of Pyridine-containing Inhibitors of 1-Deoxyxylulose-5-phosphate Reductoisomerase. ACS Med Chem Lett (2013) 0.85
Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases. J Biol Chem (2011) 0.84
Fine mapping of the sequence requirements for binding of beta-lactamase inhibitory protein (BLIP) to TEM-1 beta-lactamase using a genetic screen for BLIP function. J Mol Biol (2009) 0.83
The D-methyl group in beta-lactamase evolution: evidence from the Y221G and GC1 mutants of the class C beta-lactamase of Enterobacter cloacae P99. Biochemistry (2005) 0.82
Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase. J Mol Biol (2011) 0.81
Experimental evolution of gene duplicates in a bacterial plasmid model. J Mol Evol (2007) 0.81
Synthesis, Activity and Structure-Activity Relationship of Noroviral Protease Inhibitors. Medchemcomm (2013) 0.80
Determination of the amino acid sequence requirements for catalysis by the highly proficient orotidine monophosphate decarboxylase. Protein Sci (2011) 0.79
New antimicrobial hexapeptides: synthesis, antimicrobial activities, cytotoxicity, and mechanistic studies. ChemMedChem (2010) 0.79
Expression, characterization and inhibition of Toxoplasma gondii 1-deoxy-D-xylulose-5-phosphate reductoisomerase. Bioorg Med Chem Lett (2013) 0.78
BLIP-II is a highly potent inhibitor of Klebsiella pneumoniae carbapenemase (KPC-2). Antimicrob Agents Chemother (2013) 0.78